YN
Yigal Nochomovitz Citigroup Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
ArriVent BioPharma
AVBP
$820M
| $20.21 | $33 |
63%
upside
| Buy |
12 Aug ‘25
27 days ago |
|
2
Arcturus Therapeutics
ARCT
$487M
| $17.95 | $49 |
173%
upside
| Buy |
12 Aug ‘25
27 days ago |
|
3
Olema Pharmaceuticals
OLMA
$527M
| $7.68 | $21 |
173%
upside
| Buy |
12 Aug ‘25
27 days ago |
|
4
Zai Lab
ZLAB
$3.47B
| $31.21 | $69 |
121%
upside
| Buy |
11 Aug ‘25
28 days ago |
|
5
Biomea Fusion
BMEA
$109M
| $1.84 | $7 |
280%
upside
| Buy |
11 Aug ‘25
28 days ago |
|
6
Zymeworks
ZYME
$1.16B
| $15.27 | $22 |
44%
upside
| Buy |
11 Aug ‘25
28 days ago |
|
7
Lexicon Pharmaceuticals
LXRX
$392M
| $1.08 | $1.90 |
76%
upside
| Buy |
7 Aug ‘25
1 month ago |
|
8
Syndax Pharmaceuticals
SNDX
$1.42B
| $16.47 | $51 |
210%
upside
| Buy |
5 Aug ‘25
1 month ago |
|
9
Krystal Biotech
KRYS
$4.17B
| $144.19 | $166 |
15%
upside
| Neutral |
5 Aug ‘25
1 month ago |
|
10
Apellis Pharmaceuticals
APLS
$3.4B
| $26.92 | $52 |
93%
upside
| Buy |
1 Aug ‘25
1 month ago |
|
|
LENZ
11
LENZ Therapeutics
LENZ
$1.13B
| $39.68 | $52 |
31%
upside
| Buy |
1 Aug ‘25
1 month ago |
|
12
Sarepta Therapeutics
SRPT
$1.86B
| $17.79 | $7 |
61%
downside
| Sell |
24 Jul ‘25
1 month ago |
|
13
ProKidney
PROK
$290M
| $2.15 | $9 |
319%
upside
| Buy |
9 Jul ‘25
2 months ago |
|
14
Solid Biosciences
SLDB
$402M
| $5.16 | $14 |
171%
upside
| Buy |
26 Jun ‘25
2 months ago |
|
15
Arvinas
ARVN
$587M
| $7.99 | $9.50 |
19%
upside
| Neutral |
5 May ‘25
4 months ago |
|
16
Ardelyx
ARDX
$1.59B
| $6.59 | $10 |
52%
upside
| Buy |
2 May ‘25
4 months ago |
|
17
Summit Therapeutics
SMMT
$14.6B
| $19.68 | $35 |
78%
upside
| Buy |
26 Mar ‘25
5 months ago |
|
18
Rigel Pharmaceuticals
RIGL
$733M
| $40.88 | $55 |
35%
upside
| Buy |
6 Mar ‘25
6 months ago |
|
19
Candel Therapeutics
CADL
$281M
| $5.11 | $25 |
389%
upside
| Buy |
20 Feb ‘25
6 months ago |
|
20
CRISPR Therapeutics
CRSP
$4.98B
| $54.73 | $82 |
50%
upside
| Buy |
18 Feb ‘25
6 months ago |
|
21
EyePoint Pharmaceuticals
EYPT
$964M
| $13.98 | $33 |
136%
upside
| Buy |
7 Jan ‘25
8 months ago |
|
22
Merus
MRUS
$5.06B
| $66.85 | $97 |
45%
upside
| Buy |
9 Dec ‘24
9 months ago |
|
23
Applied Therapeutics
APLT
$65.3M
| $0.4534 | $8 |
1,664%
upside
| Buy |
29 Nov ‘24
9 months ago |
|
24
Caribou Biosciences
CRBU
$170M
| $1.83 | $6 |
228%
upside
| Buy |
26 Nov ‘24
9 months ago |
|
|
ZBIO
25
Zenas BioPharma, Inc. Common Stock
ZBIO
$891M
| $21.15 | $27 |
28%
upside
| Buy |
8 Oct ‘24
11 months ago |
|